MedPath

To evaluate how oral atenolol as a premedication will affect the hemodynamic changes during the period of pneumoperitoneum in patients undergoing laparoscopic cholecystectomy

Phase 4
Conditions
Health Condition 1: K801- Calculus of gallbladder with othercholecystitisHealth Condition 2: K00-K95- Diseases of the digestive system
Registration Number
CTRI/2024/01/061951
Lead Sponsor
Rajendra institute of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)patient giving consent

2)ASA physical status 1 and 2

3)patient with BMI between 18 to 24

Exclusion Criteria

1)Patient with contraindication to atenolol (Heart block greater than first degree, pregnant patients, asthma)

2)Coexisting cardio-respiratory disease

3)History of drug allergy, drug intake

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath